Evidence map›Paper›PMID 38276613›Full record

ArticleMolecules (Basel, Switzerland)2024

Design and Validation of a Short Novel Estradiol Aptamer and Exploration of Its Application in Sensor Technology.

Hongyan Jin, Yan Cheng, Fanli Kong, He Huang, Zhenjun Yang, Xinyi Wang, Xinxia Cai, Jinping Luo, Tao Ming

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Hongyan JinObstetrics and Gynecology Department, Peking University First Hospital, Beijing 100034, China.ORCID 0000-0002-7607-6031
Yan ChengObstetrics and Gynecology Department, Peking University First Hospital, Beijing 100034, China.
Fanli KongState Key Laboratory of Transducer Technology, Aerospace Information Research Institute, Chinese Academy of Sciences, Beijing 100190, China.
He HuangObstetrics and Gynecology Department, Peking University First Hospital, Beijing 100034, China.
Zhenjun YangState Key Laboratory of Natural & Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, No. 38 Xueyuan Road, Haidian District, Beijing 100191, China.
Xinyi WangState Key Laboratory of Transducer Technology, Aerospace Information Research Institute, Chinese Academy of Sciences, Beijing 100190, China.
Xinxia CaiState Key Laboratory of Transducer Technology, Aerospace Information Research Institute, Chinese Academy of Sciences, Beijing 100190, China.ORCID 0000-0001-5997-7252
Jinping LuoState Key Laboratory of Transducer Technology, Aerospace Information Research Institute, Chinese Academy of Sciences, Beijing 100190, China.
Tao MingInstitute of Transplantation Medicine, School of Medicine, Nankai University, Tianjin 300190, China.ORCID 0000-0003-3420-7774
Chinese Academy of Sciences · CNPeking University · CNNankai University · CN

Funding

Fundamental Research Funds for the Central Universities,Nankai University 63231174National Natural Science Foundation of China 61673024National Natural Science Foundation of China 61960206012National Natural Science Foundation of China 62121003National Natural Science Foundation of China 62171434National Natural Science Foundation of China 81971348National Natural Science Foundation of China L2224042
6 · The paper itself

Abstract

The specific and sensitive detection of 17β-estradiol (E2) is critical for diagnosing and treating numerous diseases, and aptamers have emerged as promising recognition probes for developing detection platforms. However, traditional long-sequence E2 aptamers have demonstrated limited clinical performance due to redundant structures that can affect their stability and recognition ability. There is thus an urgent need to further optimize the structure of the aptamer to build an effective detection platform for E2. In this work, we have designed a novel short aptamer that retains the key binding structure of traditional aptamers to E2 while eliminating the redundant structures. The proposed aptamer was evaluated for its binding properties using microscale thermophoresis, a gold nanoparticle-based colorimetric method, and electrochemical assays. Our results demonstrate that the proposed aptamer has excellent specific recognition ability for E2 and a high affinity with a dissociation constant of 92 nM. Moreover, the aptamer shows great potential as a recognition probe for constructing a highly specific and sensitive clinical estradiol detection platform. The aptamer-based electrochemical sensor enabled the detection of E2 with a linear range between 5 pg mL

Indexed as

Aptamers, NucleotideBiosensing TechniquesMetal NanoparticlesColorimetryEstradiolGoldLimit of DetectionAptamers, NucleotideEstradiolGold17β-estradiolaptamercolorimetricelectrochemicalmicroscale thermophoresis

Identifiers

PMID38276613
PMCPMC10819485
OpenAlexW4391089676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.